Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
Status:
Completed
Trial end date:
2016-02-28
Target enrollment:
Participant gender:
Summary
The present study assessed the therapeutic effect of exenatide and metformin as the initial
therapy in overweight/obese patients with newly diagnosed Type 2 diabetes (T2D).